Cardinal Health, Inc.

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 4, 2026, Cardinal Health, Inc. (the “Company”) appointed Anita Zielinski as its Chief Accounting Officer of the Company, effective November 5, 2026. Ms. Zielinski will succeed Mary Scherer, who will continue to serve as Chief Accounting Officer through November 5, 2026. Ms. Zielinski will join Cardinal as Senior Vice President Finance, effective September 16. Ms. Zielinski, 52, has served as interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller of Baxter International, Inc. (“Baxter”) since March 16, 2026. Ms. Zielinski joined Baxter in February 2025 as Senior Vice President, Chief Accounting Officer and Controller. Prior to joining Baxter, Ms. Zielinski worked for Sysco Corporation (“Sysco”) for seven years, including, beginning in September 2022, as Senior Vice President and Chief Financial Officer, US Foodservice Operations, the largest North American foodservice distribution business, and prior to that, beginning in April 2017, as Senior Vice President and Chief Accounting Officer. Before joining Sysco, Ms. Zielinski spent more than twenty years as a member of Ernst & Young LLP’s assurance practice, including as a Partner beginning in 2013. Ms. Zielinski does not have any family relationships with any of the Company’s directors or executive officers, there are no arrangements or understandings between Ms. Zielinski and any other persons pursuant to which she was selected for this role, and there are no transactions required to be reported by the Company under Item 404(a) of Regulation S-K for Ms. Zielinski. Ms. Zielinski will be paid (i) an annual base salary, (ii) an annual cash bonus under the Company’s Management Incentive Plan, and (iii) annual equity-based awards pursuant to the Company’s long-term incentive program and will be eligible to participate in the Company’s other benefit plans. In addition, primarily to address compensation forfeited at her former employer, Ms. Zielinski will receive (i) a cash sign on bonus of $750,000, and (ii) an initial grant of time-vesting restricted share units with a grant date value of $1,000,000 that vest ratably over three years.